Excellent
Mostly Aligned
Patient Risk:
Low
Summary
All provided statements are general brand/generic/active-ingredient identity claims and are not contradicted by the supplied labeling excerpts. The label excerpts provided do not directly address brand naming or generic interchangeability, but the statements also do not conflict with the excerpts.
Category Scores
Accurate Statements
The best-known brand name for modafinil is Provigil.
Not directly addressed in the supplied label excerpts; however, no contradiction appears in the provided labeling.
In the United States, modafinil is sold under the brand Provigil.
Not directly addressed in the supplied label excerpts; no contradiction appears in the provided labeling.
Provigil is the brand name.
Not explicitly stated in the provided excerpts; no contradiction appears in the provided labeling.
Modafinil is the active ingredient (generic name).
The supplied label excerpts refer to PROVIGIL and modafinil (e.g., Section 12.1 mechanism refers to modafinil; Section 8.4/8.5/8.6 and other sections refer to modafinil and metabolites), consistent with modafinil being the active moiety discussed alongside PROVIGIL.
Name-brand and generic products contain the same active ingredient (modafinil).
Not directly stated in the supplied excerpts; however, no contradiction appears in the provided labeling.
The active drug is the same when comparing branded modafinil to generic modafinil.
Not directly stated in the supplied excerpts; however, no contradiction appears in the provided labeling.
Unsupported Statements
Contradictions
Important Omissions
No claim text regarding indication/dosing/safety was provided that could be evaluated against Sections 1–14 (e.g., dosing, contraindications, warnings, drug interactions).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The evaluated statements are limited to identity/branding/active-ingredient equivalence and do not assert dosing, contraindications, warnings, or patient-specific use.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Label excerpts provided do not directly support brand-vs-generic identity statements (e.g., “Provigil is the best-known brand name for modafinil”); they are not contradicted, but also not explicitly verified by the supplied text.
Suggested Improvement
If evaluating brand/generic identity, include label sections (or the full label) that explicitly state the relationship between PROVIGIL and modafinil/generic products; otherwise, restrict claims to what the supplied excerpts explicitly cover.